Integrin Receptor Antagonists

Integrin Receptor Antagonist

Colitis, Ulcerative

Crohn Disease

Enteritis

<section class="Section" data-sectioncode="34089-3"><a name="S11"></a><a name="section-9"></a><p></p><h1>11 DESCRIPTION</h1><p class="First">Vedolizumab, an integrin receptor antagonist, is a humanized IgG<span class="Sub">1 </span>monoclonal antibody produced in Chinese hamster ovary cells that binds to the human α4β7 integrin. ENTYVIO has an approximate molecular weight of 147 kilodaltons.</p><div class="Section" data-sectioncode="42229-5"><a name="section-9.1"></a><p></p><p class="First"><span class="Italics Underline">Intravenous ENTYVIO</span></p><p>ENTYVIO (vedolizumab) for injection is supplied as a sterile, white to off-white, preservative-free, lyophilized cake for intravenous infusion. After reconstitution with 4.8 mL Sterile Water for Injection, USP, 0.9% Sodium Chloride Injection, USP, or Lactated Ringer's Injection, USP, the resulting concentration is 60 mg/mL with a deliverable volume of 5 mL (300 mg) and the resulting pH is approximately 6.3.</p><p>Each single-dose vial contains 300 mg vedolizumab, arginine hydrochloride (131.7 mg), histidine (23 mg), histidine monohydrochloride (21.4 mg), polysorbate 80 (3 mg), and sucrose (500 mg).</p></div><div class="Section" data-sectioncode="42229-5"><a name="section-9.2"></a><p></p><p class="First"><span class="Italics Underline">Subcutaneous ENTYVIO</span></p><p>ENTYVIO (vedolizumab) injection is supplied as a sterile, clear to moderately opalescent, colorless to slightly yellow, preservative-free solution for subcutaneous administration.</p><p>Each single-dose prefilled syringe or single-dose prefilled pen (ENTYVIO PEN) contains 108 mg vedolizumab, arginine hydrochloride (17.77 mg), citric acid monohydrate (0.18 mg), histidine (3.86 mg), histidine monohydrochloride (1.86 mg), polysorbate 80 (1.35 mg), sodium citrate dihydrate (4.71 mg) and Sterile Water for Injection, USP, at a pH of 6.5.</p></div></section>

Entyvio

vedolizumab

vedolizumab 300 MG Injection

vedolizumab 300 MG Injection [Entyvio]

0.68 ML vedolizumab 159 MG/ML Prefilled Syringe

0.68 ML vedolizumab 159 MG/ML Prefilled Syringe [Entyvio]

0.68 ML vedolizumab 159 MG/ML Auto-Injector

0.68 ML vedolizumab 159 MG/ML Auto-Injector [Entyvio]

University of Missouri Specialty Pharmacy

Actemra

Afinitor

Alecensa

Aranesp

Ayvakit

Benlysta

Braftovi

Bosulif

Cabometyx

Cotellic

Cosentyx

Enbrel

Erivedge

Erleada

Esbriet

Farydak

Fasenra

Gavreto

Ibrance

Ilaris

Imbruvica

Imfinzi

Inlyta

Inqovi

Jakafi

Koselugo

Lonsurf

Lorbrena

Lynparza

Mayvret

Mekinist

Nexavar

Nplate

Nubeqa

Ocrevus

Ofev

Olumiant

Onureg

Piqray

Promacta

Qinlock

Retacrit

Rubraca

Somatuline

Stelara

Stivarga

Sutent

Tarbrecta

Tafinlar

Tagrisso

Tarceva

Targretin

Tasigna

Tecfidera

Temodar

Tykerb

Venclexta

Vitravki

Votrient

Xolair

Xpovio

Xtandi

Yonsa

Zejula

Zelboraf

Zeposia

Zydelig

Zykadia

Entyvio | University of Missouri Specialty Pharmacy

Which health plans does University of Missouri Specialty Pharmacy have contracts with?

Does University of Missouri Specialty Pharmacy work closely with Entyvio and Takeda Pharmaceuticals America, Inc.?

Does University of Missouri Specialty Pharmacy offer services for Entyvio patients?

What conditions does University of Missouri Specialty Pharmacy support?

How does University of Missouri Specialty Pharmacy help with insurance?